http://www.progenics.com/Press_Archive/PR_2004/06-07-04%20ASCO%20PSMA.pdf page 2
For Immediate Release page 2
author: rkrawiec
Bone Pain Due to Cancer: A Specialized Approach Quadramet delivers its radioactive dose directly to these areas, thereby minimizing the effect on the surrounding normal tissues.Quadramet therapy are † : Quadramet provides relief for 62 percent to 72 percent of patients.Quadramet emits a photon, which allows for imaging.
Bone Pain FAQs Quadramet ® is a targeted radiopharmaceutical that contains radi oactive samarium153 combined with a bone-seeking agent that is used to target the drug to certain types of bone lesions.Quadramet can be prescribed by your physician t o relieve pain caused by the spread of cancer to the bone.Quadramet has provided pain relief for up to...
Cytogen: QUADRAMET Prescibing Information QUADRAMET ® is formulated as a sterile, non-pyrogenic, clear, colorless to light amber isotonic solution of samarium -153 lexidronam for intravenous administration.samarium lexidronam pentasodium is: The ionic formula is 153 Sm +3 [CH 2N(CH 2PO 3 -2 ) 2] 2 and the ionic formula weight is 581.1 daltons ...
Cytogen: About Cytogen site map contact us home SEARCH- ABOUT CYTOGEN Board of Directors Management Team PRODUCTS HEALTH CARE PROFESSIONAL PATIENT RESOURCE CENTER PIPELINE INVESTOR RELATIONS NEWSROOM CAREERS LICENSING OPPORTUNITIES About Cytogen MISSION CYTOGEN'S MISSION IS TO DEVELOP AND COMMERCIALIZE INNOVATIVE MOLECULES THAT CAN BE USED TO BUILD LEADING FRANCHISES.
Database S Samarium Sm -153 Lexidronam! Quadramet ® (3414) SARS Cysteine Proteinase Inhibitors (3403) Satraplatin (JM-216, BMS 182751, BMY 45594) (2539) SB 204269 (1894) SB 207266 (1895) SB 207499.#153; (2803) Seretide®.#153; (2398) Simdax® (Levosimendan) (1098) Sipatrigine (CEE 05-510) (1936)...
Database Q Q - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products To purchase documents on-line click on- link attached to selected document!- The fee is $15 per document Documents are delivered by e-mail...
http://www.fda.gov/cder/orange/appendix_a.txt 4, ACETAMINOPHEN PHENAPHEN-650 W/ CODEINE, ACETAMINOPHEN PHENAZINE, PHENDIMETRAZINE TARTRATE PHENAZINE-35, PHENDIMETRAZINE TARTRATE PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE PHENERGAN FORTIS, PROMETHAZINE HYDROCHLORIDE PHENERGAN PLAIN, PROMETHAZINE HYDROCHLORIDE PHENERGAN VC W/ CODEINE, CODEINE PHOSPHATE PHENERGAN VC, PHENYLEPHRINE HYDROCHLORIDE PHENERGAN W/ CODEINE, CODEINE...
2001 Warning Letters and Untitled Letters to Pharmaceutical Companies Food and Drug Administration • Center for Drug Evaluation and Research Compliance Activities Search Warning Letters and Untitled Letters to Pharmaceutical Companies 2001 These letters, sorted by month, are supplied by the CDER Freedom of Electronic Information OfficeQuadramet (Samarium Sm -153 lexidronam) injection Berlex...
Approved Biotechnology Drugs, 2002 Biotechnology Information, Advocacy and Business Support | About Us | BIO Events | BIO Members | Join BIO | Member Services | Links | Home CMS Payment System Prescription Coverage & Reimbursement Food & Agriculture Industrial & Environmental Bioethics & Biomedical Research Intellectual Property Regulatory Policies Tax & Fiscal Policies All Issues & Initiatives Press Releases Company...
BIO Editors &Reporters 03LIVE page 64
author: Elinor
PRESCRIPTION DRUG PRODUCT LIST 17TH EDITION RX DRUG PRODUCT LIST Prescription and Over-the-Counter Drug Product List - 17th Edition Cumulative Supplement Number 3: Feb '97 - Mar '97 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST - - ADD - AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; - ADD - AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; - ADD - POTASSIUM PHOSPHATE, DIBASIC; SODIUM...
FDA Drug Approvals List- April 1999 Original Application #: 050760 Approval Date: 15-APR-99 Trade Name: AMOXIL Chemical Type: 3 Therapeutic Potential: S Dosage Form: SUSPENSION Applicant: SMITHKLINE BEECHAM PHARMACEUTICALS Active Ingredient(s): AMOXICILLIN OTC/RX Status: RX Indication(s):For the use of Amoxil for oral suspension 200mg/5mL and 400mg/5mL in divided doses q12h Original Application #: 020924 Approval Date:...
CPMP_PR_209_98 The EuropeanAgency for the Eval u ati on of Medi cinal Products Human Medicines Evaluation Unit 7 Westferry Cir cu s, Canary Wharf, E14 4HB, UK Swit chboard: (+ 44- 171) 418 840 0 Fax: (+ 44- 171) 418 8551 E_M ail: mail @emea. eudra. org http: //w w w. eudra. org/ emea. html 27 February 1998 CPMP/ 209/ 98 PRESS ...
author: WELLS
CPMP_PR_209_98 page 5 CPMP/ 209/ 98 5/ 15 QUADRAMET International Non- proprietary Name (INN): Samarium [ 153 Sm] lexidronam pentasodium Abstract On 5 February 1998 the European Commission issued a Marketing Authorisation valid throughout the European Union for the medicinal product Quadramet, which contains samarium ...
author: WELLS
Medicinal Products with a Community Marketing authorisation - Status October 2002 page 8 List Medicinal Products granted a Community Marketing Authorisation under the Centralised Procedure Product a) Brandname b) INN c) Part A/ B Company a) Name b) Origin Therapeutic Area a) ATC b) Indication Presentation a) Form b) Strengths c) Number of Presentations EMEA/ CPMP a) Validation b) Opinion ...
author: EMEA
subject: List
Medicinal Products with a Community Marketing authorisation, Status-September 2002 page 8 Table Medicinal Products granted a Community Marketing Authorisation under the Centralised Procedure Product a) Brandname b) INN c) Part A/ B Company a) Name b) Origin Therapeutic Area a) ATC b) Indication Presentation a) Form b) Strengths c) Number of Presentations EMEA/ CPMP a) Validation b) Opinion ...
author: EMEA
subject: Table
duplicates:http://www.emea.eu.int/pdfs/general/direct/listprod/1640502en.pdf
Dowpharma and Cytogen Agree to Develop PSMA Antibody for Treatment of Cancer About Cytogen Corporation Founded in 1980, Cytogen Corporation of Princeton, NJ is a product-driven biopharmaceutical company that develops and commercializes innovative molecules that can be used to build leading franchises.- Cytogen's marketed products include QUADRAMET(r) (samarium Sm -153 lexidronam injection) and PROSTASCINT(r) (capromab pendetide) kit for...
http://www.adis.com/files/newsletters/PT/Ptcov40.pdf 4 Fentanyl (intranasal): adequate postoperative analgesia 3 Fluticasone propionate (inhaled) suppresses adrenal function 8 G- CSF after autologous peripheral blood progenitor cell transplantation 9 Helicobacter pylori infection: updated guidelines issued 2 Hospitalisation costs: adult vs paediatric patients 9 Late anthracycline toxicity in children 9 Leuprorelin (depot): serum LH...
http://www.adis.com/files/newsletters/CTD/Cdcov39.pdf 7 Idebenone vs tacrine in Alzheimer's disease 5 IFN- - 1b vs glatiramer acetate in MS 4 IFN- - 1b effective in secondary- progressive MS 5 IFN- - 1b: long- term efficacy and tolerability in MS 5 Migraine: stratified care strategy cost effective 8 Mirtazapine (IV) effective in depression 5 Mood stabilisers + antipsychotics in acute mania 6 Mood stabilisers + citalopram in bipolar...
http://www.adis.com/files/newsletters/INP/Icov1327.pdf CANCER Antineoplastics associated with gynaecomastia 22 Antineoplastics + rituximab in mantle cell lymphoma 10 Bicalutamide: priority review for new indication in the US 22 Dronabinol ± megestrol in cancer- related anorexia 14 Ibritumomab tiuxetan approved in the US 22 Imatinib mesylate: effects on bone marrow fibrosis in CML 19 Irinotecan + oxaliplatin vs raltitrexed in...
may20lst.PDF Iofetamine I- 123 Radioactive diagnostic- nonlacunar stroke Yes Yes Yes Yes Iopromide Aortography and visceral angiography coronary arteriography/ left ventriculography Yes Yes No No Iotrolan For contrast enhancement for lumbar, thoracic, cervical and total columnar myelography of spinal and subarachnoid spaces Yes Yes Yes Yes Ioversol Radiopaque diagnostic (cerebral angiography and...
author: Unknown
may20lst.PDF page 10
author: Unknown
FDA Drug Approvals List Drug Approvals for March 1997 Definitions and Notes March 1997 Original New Drug Applications Original Application #: 020570 Approval Date: 28-MAR-97 Trade Name: QUADRAMET Chemical Type: 1 Therapeutic Potential: S Dosage Form: INJECTABLE Applicant: CYTOGEN CORP Active Ingredient(s): SAMARIUM SM 153 EDTMP OTC/RX Status: RX Indication(s): For relief of pain in...
